Toronto: A drug commonly used as the front-line treatment for type-2 diabetes may also be effective in reducing weight in children and adolescents with autism spectrum disorder (ASD), finds a study.
ASD is a serious developmental disorder that impairs the ability to communicate and interact.
Individuals suffering from autism spectrum disorder take atypical antipsychotics drugs to treat symptoms of irritability and agitation. These drugs often increases their appetite as well as weight, thus raising a long-term risk of diabetes.
The study explored the effectiveness of metformin drug in counteracting weight gain associated with antipsychotics.
The findings showed that, overall, metformin was well tolerated, and reduced Body Mass Index (BMI) scores from the initial baseline.
"Use of antipsychotics to help manage irritability associated with ASD can sometimes be long-term, which means we need to provide families with solutions that support lasting optimal health in their children," said lead researcher Evdokia Anagnostou, Scientist from the University of Toronto, Canada.
However, the participants experienced gastrointestinal adverse events during a higher percentage of treatment days, the researchers said.
"Our results showed that gastrointestinal side effects occurred for more days in the metformin group compared to placebo group, but the large majority of children taking metformin were able to maintain their treatment," said Michael Aman, Professor at The Ohio State University, in the US.
Importantly, the metformin didn't cause behavioural changes, such as increased irritability, the authors noted, in the paper published in the Journal of the American Medical Association Psychiatry.
For the study, the team conducted a double-blind, randomised clinical trial for 16 weeks on 60 adolescents and children (ages 6-7) with ASD who were overweight due to side effects of antipsychotic medications.
(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)
ASD is a serious developmental disorder that impairs the ability to communicate and interact.
Individuals suffering from autism spectrum disorder take atypical antipsychotics drugs to treat symptoms of irritability and agitation. These drugs often increases their appetite as well as weight, thus raising a long-term risk of diabetes.
The findings showed that, overall, metformin was well tolerated, and reduced Body Mass Index (BMI) scores from the initial baseline.
Advertisement
However, the participants experienced gastrointestinal adverse events during a higher percentage of treatment days, the researchers said.
Advertisement
Importantly, the metformin didn't cause behavioural changes, such as increased irritability, the authors noted, in the paper published in the Journal of the American Medical Association Psychiatry.
Advertisement
Advertisement
COMMENTS
Advertisement
Nutritionist Explains 3 Things To Keep In Mind If You Have Type-2 Diabetes UK Woman Claims She Was Kicked Off Flight ''For Having Diabetes'' Pre-Diabetes: Lifestyle & Diet Changes To Prevent Type-2 Diabetes 25,000 Aspirants For Airport Jobs Paying Rs 22,000: A Mumbai Stampede Scare Siddaramaiah Deletes Post On 100% Quota Bill, Karnataka Minister Clarifies Prank Goes Wrong: Woman Falls From 3rd Floor In Mumbai Building, Dies When Oberoi Hotel Denied Late Check-Out to Billionaire Michael Dell Huge Fire At Gulati Restaurant In Delhi's Pandara Road, No Casualty "This Is The Final Straw": Elon Musk Moving X And SpaceX Out Of California Track Latest News Live on NDTV.com and get news updates from India and around the world.